NCT05478928

Brief Summary

Myofascial pain syndrome (MPS) is present in up to 87% of the patients that present pain. MPS usually presents painful myofascial trigger points (MTrPs). One methodology used to quantify the pain in MPS is the algometry, which measures the pressure pain threshold (PPT). Invasive techniques in physiotherapy have become popular in the last years due to their clinical efficacy and evidence. Percutaneous Microelectrolysis (MEP®) and dry needling are techniques that are already in use for this syndrome. MEP® is a technique that employs a galvanic current up to 990 microAmperes, which is applied percutaneously with an acupuncture needle connected to the cathode. It is also known as low intensity percutaneous electrolysis. The aim of this study is to compare the effects in pain and muscle tone (measured with algometry and surface electromyography) of invasive techniques. Healthy subjects between 18 to 48 years old, both sex, presenting MTrPs in upper trapezius will be recruited. The secondary objectives are to determine the discomfort degree of each technique and if it is better to use MEP® with a fixed dose or with an algorithm in which the dose varies. The hypothesis, according to our previous studies, is that MEP® generates higher changes in PPT.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 28, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

August 15, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2023

Completed
Last Updated

July 28, 2022

Status Verified

July 1, 2022

Enrollment Period

1 year

First QC Date

July 25, 2022

Last Update Submit

July 26, 2022

Conditions

Keywords

Trigger pointPercutaneousElectrolysisPhysical Therapy Modalities

Outcome Measures

Primary Outcomes (15)

  • Pressure Pain Threshold (PPT) - Baseline

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

    Baseline

  • Pressure Pain Threshold (PPT) - 10 minutes

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

    10 minutes

  • Pressure Pain Threshold (PPT) - 24 hours

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

    24 hours

  • Pressure Pain Threshold (PPT) - 48 hours

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

    48 hours

  • Pressure Pain Threshold (PPT) - Day 7

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

    Day 7

  • Surface electromyography at rest - Baseline

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

    Baseline

  • Surface electromyography at rest - 10 minutes

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

    10 minutes

  • Surface electromyography at rest - 24 hours

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

    24 hours

  • Surface electromyography at rest - 48 hours

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

    48 hours

  • Surface electromyography at rest - Day 7

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

    Day 7

  • Surface electromyography at maximum voluntary contraction - Baseline

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

    Baseline

  • Surface electromyography at maximum voluntary contraction - 10 minutes

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

    10 minutes

  • Surface electromyography at maximum voluntary contraction - 24 hours

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

    24 hours

  • Surface electromyography at maximum voluntary contraction - 48 hours

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

    48 hours

  • Surface electromyography at maximum voluntary contraction - Day 7

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

    Day 7

Secondary Outcomes (3)

  • Visual Analogue Scale of the procedure

    Immediately after the intervention

  • Post-needling soreness

    Four times per day (in the morning, before lunch, in the afternoon, and in the evening) during the seven days following intervention.

  • Dose

    Immediately after the intervention

Study Arms (6)

Dynamic dry needling

EXPERIMENTAL

Dynamic dry needling will be done in the upper trapezius trigger point.

Other: Dynamic dry needling

Fixed dose dynamic MEP

EXPERIMENTAL

Dynamic low intensity percutaneous electrolysis will be applied in the upper trapezius trigger point with a fixed dose.

Device: Fixed dose dynamic MEP

Static dry needling:

EXPERIMENTAL

Static dry needling will be done in the upper trapezius trigger point.

Other: Static Dry needling

Fixed dose static MEP

EXPERIMENTAL

Static low intensity percutaneous electrolysis will be applied in the upper trapezius trigger point with a fixed dose.

Device: Fixed dose static MEP

Algorithm-based dose static MEP

EXPERIMENTAL

Low intensity percutaneous electrolysis will be applied in the upper trapezius trigger point with an algorithm-based dose.

Device: Algorithm-based dose static MEP

Placebo

PLACEBO COMPARATOR

An acupuncture needle will be slightly introduced into the upper trapezius trigger point.

Other: Placebo

Interventions

An acupuncture needle of 0.3 x 25 mm will be introduced perpendicularly into the upper trapezius trigger point. A movement with the needle will be done at 1 Hz for 120 seconds.

Dynamic dry needling

Cathodic low intensity percutaneous electrolysis will be applied through an acupuncture needle of 0.3 x 25 mm in the upper trapezius trigger point. A movement with the needle will be done at 1 Hz with an intensity of 600 micro-Amperes. If the patient refers discomfort, the procedure will be stopped and resumed totalling 120 seconds (total dose of 72 mC).

Fixed dose dynamic MEP

An acupuncture needle of 0.3 x 25 mm will be introduced perpendicularly into the upper trapezius trigger point for 120 seconds.

Static dry needling:

Cathodic low intensity percutaneous electrolysis will be applied through an acupuncture needle of 0.3 x 25 mm in the upper trapezius trigger point. The therapy will be done statically with an intensity of 600 micro-Amperes. If the patient refers discomfort, the procedure will be stopped and resumed totalling 120 seconds (total dose of 72 mC).

Fixed dose static MEP

Cathodic low intensity percutaneous electrolysis will be applied through an acupuncture needle of 0.3 x 25 mm in the upper trapezius trigger point. The therapy will be done statically, at 600 micro-Amperes. If the patient refers discomfort, the procedure will be stopped and resumed. Treatment will finish when the patient does not refer any discomfort for a period longer than 60 seconds. Total dose in mC will be registered.

Algorithm-based dose static MEP
PlaceboOTHER

An acupuncture needle of 0.3 x 25 mm will be introduced perpendicularly up to 3 mm deep into the upper trapezius trigger point for 120 seconds.

Placebo

Eligibility Criteria

Age18 Years - 48 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Neck pain during the last 6 months
  • Presence of a palpable taut band in the upper trapezius
  • Presence of a hypersensitive tender spot in the taut band, with local or referred pain elicitation in response to compression
  • PPT less than 3 Kg/cm2

You may not qualify if:

  • Previous cervical and/or shoulder surgical intervention.
  • Phobia to needles.
  • Temporomandibular disorders.
  • Medicated with anticoagulants
  • Still receiving a treatment for the myofascial trigger points (Physical therapy, NSAIDs, etc.)
  • Diagnosis of fibromyalgia.
  • Radiculopathies and/or radicular pain
  • Whiplash related neck pain
  • Migraines
  • Dizziness
  • Endocrinal diseases
  • Being pregnant
  • Cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Maimónides

Buenos Aires, Buenos Aires F.D., 1405, Argentina

RECRUITING

Related Publications (1)

  • Girasol CE, Duran NE, D'Almeida SM, Ronzio OA. Toward an algorithm of percutaneous microelectrolysis: a randomized clinical trial on invasive techniques. Sao Paulo Med J. 2025 Aug 11;143(5):e2024164. doi: 10.1590/1516-3180.2024.0164.R1.07032025. eCollection 2025.

MeSH Terms

Conditions

Myofascial Pain Syndromes

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal Diseases

Central Study Contacts

Oscar Ronzio, DHSc PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Physiotherapy program

Study Record Dates

First Submitted

July 25, 2022

First Posted

July 28, 2022

Study Start

August 15, 2022

Primary Completion

August 15, 2023

Study Completion

August 15, 2023

Last Updated

July 28, 2022

Record last verified: 2022-07

Locations